Diamicron Mr Gliclazide 60 Mg 30 Tablets

Diamicron Mr Gliclazide 60 Mg 30 Tablets

Description:

Diamicron MR gliclazide 60 mg is an oral antidiabetic prescription medicine from the sulfonylurea class, formulated as modified-release tablets for once-daily blood sugar control in adults with type 2 diabetes mellitus. It helps lower and stabilize blood glucose levels by stimulating insulin secretion from the pancreas and improving the body’s response to insulin, supporting long-term diabetes management alongside diet and exercise.

Indications:

• Management of type 2 diabetes mellitus in adults when blood glucose cannot be adequately controlled by diet, physical activity, and weight reduction alone.
• Helps reduce elevated fasting and postprandial (after-meal) blood glucose levels.
• May be used as monotherapy or in combination with other oral antidiabetic agents (such as metformin) or insulin, as prescribed by a physician.
• Aims to reduce the risk of long-term diabetes complications (such as cardiovascular, renal, and eye complications) through improved glycemic control.

Active Ingredients / Key Components:

• Gliclazide – 60 mg per modified-release tablet.
• Excipients (tablet core and coating) – exact composition and concentrations are not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.); please refer to the official package leaflet for the full excipient list.

Dosage & Administration / How to Use:

• Use exactly as prescribed by your physician. Do not change the dose or stop the medicine without medical advice.
• Typical adult dose: 1 tablet (60 mg) once daily, taken at breakfast. The dose may be adjusted by the doctor based on blood glucose response. Some patients may require a lower or higher dose (e.g., 30–120 mg/day) using appropriate tablet strengths as directed by the physician.
• Swallow the modified-release tablet whole with a glass of water. Do not crush, chew, or break the tablet, as this may alter the modified-release profile and increase the risk of hypoglycemia.
• Always take with food (preferably the first main meal of the day) to reduce the risk of low blood sugar.
• If you miss a dose, take it as soon as you remember on the same day with food. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not take a double dose to make up for a missed tablet.
• Regular monitoring of blood glucose and HbA1c is recommended to assess treatment effectiveness and adjust the dose.
• Use with caution in elderly patients or those at higher risk of hypoglycemia; close medical supervision is required.

Clinical Benefits:

• Provides effective blood glucose lowering in type 2 diabetes by increasing insulin release from pancreatic beta cells.
• Modified-release formulation allows once-daily dosing, helping maintain more stable 24-hour glycemic control and improving treatment adherence.
• Improves glucose tolerance and enhances tissue sensitivity to insulin, supporting better metabolic control.
• Helps reduce the risk of diabetes-related long-term complications when used as part of a comprehensive diabetes management plan (diet, exercise, regular monitoring).

Warnings & Contraindications:

• Contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis, diabetic pre-coma or coma, and in patients with severe renal or severe hepatic impairment (insulin therapy is usually required in these situations).
• Do not use if you have known hypersensitivity or allergy to gliclazide, other sulfonylureas, sulfonamides, or any component of the tablet.
• Not recommended during pregnancy or breastfeeding; insulin is generally preferred. Consult your doctor for appropriate treatment options.
• Use with caution in elderly, malnourished, or debilitated patients, and in those with adrenal or pituitary insufficiency, as these conditions increase the risk of hypoglycemia.
• Alcohol intake may potentiate the hypoglycemic effect and should be avoided or minimized. Inform your doctor if you consume alcohol regularly.
• Beta-blockers and some other medicines may mask the symptoms of hypoglycemia (such as palpitations and tremor). Inform your doctor about all medications you are taking, including other antidiabetic drugs, blood pressure medicines, anticoagulants, and steroids.
• Driving and operating machinery: Hypoglycemia can impair concentration and reaction time. Use caution when driving or operating machines, especially when treatment is initiated or doses are changed.
• Consult your doctor before use if you have liver disease, kidney disease, hormonal disorders, cardiovascular disease, or if you are at risk of severe hypoglycemia.
• Keep out of reach of children.

Side Effects:

• Common: Hypoglycemia (low blood sugar) with symptoms such as sweating, hunger, headache, dizziness, palpitations, tremor, irritability, confusion, or blurred vision. Mild episodes can usually be corrected by taking fast-acting carbohydrates (e.g., glucose tablets, sugary drink). Severe hypoglycemia may require medical attention.
• Less common: Nausea, vomiting, abdominal pain, indigestion, diarrhea or constipation.
• Rare: Skin reactions such as rash, itching, redness, or urticaria; photosensitivity reactions.
• Very rare but serious: Severe allergic reactions, liver function disturbances (cholestatic jaundice, hepatitis), blood disorders (e.g., anemia, leukopenia, thrombocytopenia). If you notice yellowing of the skin or eyes, unusual bruising, bleeding, fever, or persistent sore throat, seek medical attention immediately.
• If you experience signs of severe hypoglycemia (loss of consciousness, seizures) or any severe allergic reaction (swelling of face, lips, tongue, or throat; difficulty breathing), seek emergency medical help.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and moisture. Keep the blister pack in the outer carton to protect from light. Do not store above the temperature specified on the package (exact temperature range not available in the provided information; refer to the product carton). Keep container tightly closed and keep out of reach of children.

Specifications:

• Form: Modified-release tablets for oral use.
• Strength: 60 mg gliclazide per tablet.
• Count: 30 tablets per pack.
• Intended use: Prescription oral antidiabetic medicine for adults with type 2 diabetes mellitus.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.